LAWYER PROFILE
Kenneth A Clark

Kenneth A Clark

USA 2026

Chambers ranking badge
Chambers ranking badge

Ranked in 1 practice area

About

Provided by Wilson Sonsini Goodrich & Rosati

Practice Areas

Ken Clark serves as general counsel to companies and their boards of directors, primarily in the biotechnology industry. Ken has extensive expertise in partnering and strategic transactions, having negotiated more than 100 major strategic alliance and M&A transactions. He also regularly represents companies in financings, spin-outs, and related matters.

Ken served on the firm's board of directors from 2011 to 2014 and from 2002 to 2006, and previously was a member of the firm's Policy Committee. Ken served as a director of Pharmacyclics, Inc. (NASDAQ: PCYC) from 2012 until their sale to AbbVie in 2015.

Chambers Review

Provided by Chambers

Chambers Guide to the USA

Life Sciences: Corporate/Commercial - California

Band 1
Band 1

Individual Editorial

Kenneth Clark is frequently called upon to represent life sciences clients in a broad array of corporate transactions including strategic agreements, M&A, financings and spinouts.

Life Sciences: Corporate/Commercial - USA - Nationwide

Band 3
Band 3

Individual Editorial
Kenneth Clark advises biotechnology businesses on the full span of corporate transactional processes, such as partnerships and strategic alliances, financings and spinouts, and mergers and acquisitions.

Strengths

Provided by Chambers

  • Kenenth is an excellent attorney with a great reputation for medical devices work.

    Life Sciences: Corporate/CommercialChambers Guide to the USA
  • Kenneth is a well-known attorney who is easy to work with and produces high-quality work.

    Life Sciences: Corporate/CommercialChambers Guide to the USA

Ranked Individuals at Wilson Sonsini Goodrich & Rosati (115)

California

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership